NCT02624518View on ClinicalTrials.gov

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

November 16, 2015

Primary Completion Date

July 21, 2021

Study Completion Date

November 30, 2022

Conditions
Prostate Adenocarcinoma
Interventions
DRUG

68Ga-RM2

Imaging with PET/MRI

PROCEDURE

Magnetic Resonance Imaging

Imaging with 68Ga-RM2 PET/MRI

PROCEDURE

Positron Emission Tomography

Imaging with 68Ga-RM2 PET/MRI

Trial Locations (1)

94304

Stanford University, School of Medicine, Palo Alto

All Listed Sponsors
lead

Andrei Iagaru

OTHER

NCT02624518 - 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer | Biotech Hunter | Biotech Hunter